Description

3-Cyclohexyl-9-Methyl-8,9,10,11-Tetrahydro[1]Benzothieno[3,2-E][1,2,4]Triazolo[4,3-C]Pyrimidine is a high-purity, complex heterocyclic compound that serves as a critical advanced intermediate in modern pharmaceutical research and development. Its intricate fused-ring structure makes it a valuable scaffold for synthesizing novel bioactive molecules, particularly in the discovery of central nervous system (CNS) and enzyme-targeting therapeutics. This compound is essential for medicinal chemists and R&D teams in pharmaceutical and biotechnology companies seeking to develop new drug candidates with specific target affinity.

Application

• Pharmaceutical Intermediate: A key building block in the synthesis of novel drug candidates, particularly for neurological and psychiatric disorders.
• Medicinal Chemistry Research: Used as a core scaffold for structure-activity relationship (SAR) studies and library synthesis in hit-to-lead optimization.
• Biochemical Tool Compound: Serves as a reference standard or probe in enzymatic assays and receptor binding studies to understand biological pathways.
• Preclinical Development: Employed in the production of compounds for pharmacokinetic, pharmacodynamic, and toxicology evaluations.
• Contract Research & Manufacturing (CRO/CMO): Supplied to service organizations supporting outsourced drug discovery and development programs.
• Academic Research: Utilized in university and institutional labs for fundamental research in organic synthesis and pharmacology.

Basic Information

Product Name	3-Cyclohexyl-9-Methyl-8,9,10,11-Tetrahydro[1]Benzothieno[3,2-E][1,2,4]Triazolo[4,3-C]Pyrimidine
CAS No.	442571-05-3
Molecular Formula	C20H22N4S
Molecular Weight	350.48 g/mol
Synonyms	3-Cyclohexyl-9-methyl-8,9,10,11-tetrahydro[1]benzothieno[3,2-e][1,2,4]triazolo[4,3-c]pyrimidine; Benzothienotriazolopyrimidine derivative; CAS 442571-05-3; Tetrahydrobenzothienotriazolopyrimidine; 8,9,10,11-Tetrahydro[1]benzothieno[3,2-e][1,2,4]triazolo[4,3-c]pyrimidine, 3-cyclohexyl-9-methyl-; Advanced Pharmaceutical Intermediate 442571-05-3
EINECS	Contact for details

Quality Control

Every batch of 3-Cyclohexyl-9-Methyl-8,9,10,11-Tetrahydro[1]Benzothieno[3,2-E][1,2,4]Triazolo[4,3-C]Pyrimidine is manufactured and tested under a strict quality management system. Our products undergo rigorous quality testing to ensure compliance with industry standards for advanced pharmaceutical intermediates. Certificates of Analysis (COA) detailing purity, identity, and impurity profiles are available upon request, providing full traceability and batch-specific data to support your regulatory and research needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). Keep the container tightly sealed in a dry environment to protect the compound from moisture. For long-term storage, consider storing under an inert atmosphere.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Any single unknown impurity	≤ 0.5%
Residual Solvents (GC)	Complies with ICH Q3C guidelines
Water Content (KF)	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.